Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: Long-term follow-up

A. Shimoni; I. Hardan; N. Shem-Tov; R. Yerushalmi; A. Nagler

doi:10.1038/leu.2010.12

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: Long-term follow-up

A. Shimoni^*, I. Hardan, N. Shem-Tov, R. Yerushalmi, A. Nagler

^*Corresponding author for this work

Sheba Medical Center at Tel Hashomer

Research output: Contribution to journal › Letter › peer-review

39 Scopus citations

Original language	English
Pages (from-to)	1050-1052
Number of pages	3
Journal	Leukemia
Volume	24
Issue number	5
DOIs	https://doi.org/10.1038/leu.2010.12
State	Published - May 2010
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/leu.2010.12

Cite this

@article{030a6ac2653e4044af3c5f6001bca8b4,

title = "Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: Long-term follow-up",

author = "A. Shimoni and I. Hardan and N. Shem-Tov and R. Yerushalmi and A. Nagler",

year = "2010",

month = may,

doi = "10.1038/leu.2010.12",

language = "אנגלית",

volume = "24",

pages = "1050--1052",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "5",

}

TY - JOUR

T1 - Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning

T2 - Long-term follow-up

AU - Shimoni, A.

AU - Hardan, I.

AU - Shem-Tov, N.

AU - Yerushalmi, R.

AU - Nagler, A.

PY - 2010/5

Y1 - 2010/5

UR - http://www.scopus.com/inward/record.url?scp=77952428379&partnerID=8YFLogxK

U2 - 10.1038/leu.2010.12

DO - 10.1038/leu.2010.12

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.letter???

C2 - 20147978

AN - SCOPUS:77952428379

SN - 0887-6924

VL - 24

SP - 1050

EP - 1052

JO - Leukemia

JF - Leukemia

IS - 5

ER -

Allogeneic hematopoietic stem-cell transplantation in AML and MDS using myeloablative versus reduced-intensity conditioning: Long-term follow-up

UN SDGs

Access to Document

Other files and links

Cite this